CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −2,237 | $93.85 | $210K | 239,147 |
| 2026-07-01 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −2,263 | $94.75 | $214K | 236,884 |
| 2026-07-01 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −500 | $95.47 | $48K | 236,384 |
| 2026-07-01 | Sandler Laura Lee Chief Operating Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −5,000 | 79,996 | ||
| 2026-06-22 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −888 | $80.01 | $71K | 16,011 |
| 2026-06-22 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −699 | $82.15 | $57K | 15,312 |
| 2026-06-15 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −395 | $69.69 | $28K | 16,899 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 37,165 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 40,665 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −1,636 | $68.38 | $112K | 39,029 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −5,064 | $69.42 | $352K | 33,965 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −300 | $70.62 | $21K | 33,665 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −947 | $69.69 | $66K | 32,718 |
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 204,063 | ||
| 2026-06-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 175,492 | ||
| 2026-06-15 | Klein Lawrence Otto Chief Executive Officer | Sale | −1,729 | $69.69 | $120K | 925,580 |
| 2026-06-15 | Sandler Laura Lee Chief Operating Officer | Sale | −600 | $69.69 | $42K | 236,384 |
| 2026-06-15 | Quinlan Paul T General Counsel | Sale | −733 | $69.69 | $51K | 31,034 |
| 2026-06-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +8,000 | $12.50 | $100K | 25,294 |
| 2026-06-12 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +1,459 | $34.39 | $50K | 26,753 |
Page 8 of 18 · 346 trades